Search Press releases Keywords From To 25 Apr 2024 UCB’s General Meeting of Shareholders 2024 Read More 25 Apr 2024 UCB off to a Good Start into 2024 – Progressing on its Growth Path for a Decade Plus Read More 23 Apr 2024 Transparency notification FMR LLC Read More 22 Apr 2024 UCB receives European Commission approval for BIMZELX[®]▼(bimekizumab) as the first IL-17A and IL-17F biologic for moderate to severe hidradenitis suppurativa Read More 19 Apr 2024 Acquisition of own shares Read More 17 Apr 2024 FINTEPLA[®]▼ (fenfluramine) oral solution approved in Japan for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) Read More Pagination First page Previous page Previous … Page 11 Page 12 Page 13 Page 14 Current page 15 Page 16 Page 17 Page 18 Page 19 … Page 15 of 67 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe